.25mg of semaglutide Medscape | The FDA has approved once-daily oral 25 mg (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. ⁠ Obesity | Novo Nordisk U.S.

However, both should be prescribed and monitored by a licensed physician, as combining peptide therapy with other metabolic interventions increases the complexity of dosing and side effect management

the addition of even potential benefit to longevity via a common mechanism with 17-estradiol only further improves the risk-reward tradeoff of 5AR inhibition

As powerful as semaglutide is, it does come with limitations and risks

Therapy and support for those with ADHD may involve behavioral therapy, cognitive-behavioral therapy, behavioral classroom management and accommodation, stress management strategies, and support groups